Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: Pharmaceuticals & Biotechnology
|Large Cap
Gland Pharma Ltd.
₹1,745.10
Invest in GLAND with up to 2.50x margin.
Trade with MTF₹1721.80
₹1755.60
₹1342.00
₹2131.00
Markets Today
Historical Performance
Indicator | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|
| Total Revenue | 1,177.51 | 1,074.15 | 1,038.84 | 1,030.35 | 1,010.78 |
| Operating Expense | 755.89 | 699.26 | 679.99 | 636.23 | 619.64 |
| Operating Profit | 421.63 | 374.89 | 358.84 | 394.12 | 391.14 |
| Depreciation | 44.53 | 44.84 | 43.77 | 43.07 | 43.77 |
| Interest | 0.50 | 3.97 | 7.44 | 3.45 | 18.31 |
| Tax | 104.61 | 106.68 | 93.12 | 101.32 | 99.01 |
| Net Profit | 307.85 | 302 | 269.26 | 290 | 295.12 |
₹1745.10
↗ Bullish Moving Average
11
↘ Bearish Moving Average
5
| Held By | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|
| Promoter | 51.8 | 51.8 | 51.8 | 51.8 | 51.8 | 51.8 |
| FII | 4.5 | 5 | 6.9 | 7.4 | 7.9 | 7.6 |
| DII | 35.3 | 34.8 | 33.3 | 32.8 | 32.6 | 33 |
| Public | 8.3 | 8.3 | 8 | 7.9 | 7.6 | 7.6 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 19.07 K | 42.31 K | 45.07% |
| Week | 81.25 K | 1.23 L | 66.09% |
| 1 Month | 68.48 K | 1.15 L | 59.43% |
| 6 Month | 86.89 K | 1.64 L | 52.89% |
Benjamin Graham Value Screen
Stocks in Buy Zone with High Momentum Score Last Month
Buy Zone: Stocks in the buy zone based on days traded at current PE and P/BV
Mid-range Performer (DVM)
Relative Outperformance versus Industry over 1 Month
Companies with high TTM EPS Growth
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Growth in Net Profit with increasing Profit Margin (QoQ)
Companies with Low Debt
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Top Gainers
Stocks Outperforming their Industry Price Change in the Quarter
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 14 Aug, 2025 | 18 | FINAL | 14 Aug, 2025 | Equity Share |
| 16 Aug, 2024 | 20 | FINAL | 16 Aug, 2024 | Equity Share |
Financials | |||||
|---|---|---|---|---|---|
| Price (₹) | ₹720 | ₹975 | ₹1,604 | ₹2,053 | ₹1,081.95 |
| % Change | 4.24% | 0.15% | 2.47% | 0.54% | -0.05% |
| Revenue TTM (₹ Cr) | ₹1,996.59 | ₹2,169.86 | ₹8,850.08 | ₹13,914.08 | ₹6,721.63 |
| Net Profit TTM (₹ Cr) | ₹484.66 | ₹332.94 | ₹869.92 | ₹1,779.35 | ₹843.32 |
| PE TTM | 83.50 | 62.20 | 35.00 | 47.70 | 69.40 |
| 1 Year Return | 26.36 | 43.56 | 70.22 | -12.49 | 87.09 |
| ROCE | 26.88 | 12.51 | 20.80 | 13.27 | 11.82 |
Alkem Laboratories Ltd.
₹ 5385.00
+2.65%
Biocon Ltd.
₹ 345.95
-1.10%
Divi's Laboratories Ltd.
₹ 5955.50
+1.25%
Ajanta Pharma Ltd.
₹ 2750.00
+1.51%
Zydus Lifesciences Ltd.
₹ 900.00
-
Glenmark Pharmaceuticals Ltd.
₹ 2161.80
-0.54%
Wockhardt Ltd.
₹ 1365.00
+1.13%
Aurobindo Pharma Ltd.
₹ 1339.20
+0.26%
Sun Pharmaceutical Industries Ltd.
₹ 1715.00
+0.02%
Ipca Laboratories Ltd.
₹ 1450.00
+0.35%
J B Chemicals & Pharmaceuticals Ltd.
₹ 1965.10
+1.16%
GlaxoSmithKline Pharmaceuticals Ltd.
₹ 2357.00
+0.11%
Pfizer Ltd.
₹ 4735.00
-2.08%
Abbott India Ltd.
₹ 25765.00
-0.33%
Torrent Pharmaceuticals Ltd.
₹ 4090.00
+1.51%
Lupin Ltd.
₹ 2292.30
-0.08%
Dr. Reddy's Laboratories Ltd.
₹ 1211.00
+1.65%
Cipla Ltd.
₹ 1225.00
+0.75%
By signing up I certify terms, conditions & privacy policy